Moderna Total Non-Operating Income/Expense 2017-2024 | MRNA
Moderna total non-operating income/expense for the twelve months ending June 30, 2024 was $303M, a 0.66% decline year-over-year.
- Moderna annual total non-operating income/expense for 2023 was $0.297B, a 91.61% increase from 2022.
- Moderna annual total non-operating income/expense for 2022 was $0.155B, a 1509.09% decline from 2021.
- Moderna annual total non-operating income/expense for 2021 was $-0.011B, a 157.89% decline from 2020.